That’s the question the government must address say the OPPI.
According to an article by the Organisation of Pharmaceutical Producers of India (OPPI), price control is neither a viable nor sustainable strategy for increasing access to medicines. Director general of Organisation of Pharmaceutical Producers of India (OPPI), Ranjana Smetacek said “The focus must shift from controlling prices to collaboratively advancing a common agenda.”
